Patents Assigned to IMBiotechnologies Ltd
  • Patent number: 7947282
    Abstract: The present invention relates generally to methods and compositions for treating a disease or condition by administering a first therapeutic protocol comprising targeting and delivering solid-phase platelet-dependent vascular occlusion agents, and administering at least one second therapeutic composition or method.
    Type: Grant
    Filed: August 14, 2006
    Date of Patent: May 24, 2011
    Assignee: IMBiotechnologies Ltd
    Inventors: Michael W. Stewart, Antoine Noujaim, Bruce D. Hirsche, legal representative, Roland H. Person